SARS-CoV-2 Nucleocapsid anticorps (AA 121-422)
Aperçu rapide pour SARS-CoV-2 Nucleocapsid anticorps (AA 121-422) (ABIN7469590)
Antigène
Voir toutes SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 121-422
-
Specificité
- This antibody detects both SARS-CoV nucleocapsid and SARS-CoV-2 nucleocapsid proteins. Our internal testing indicates no cross-reactivity with MERS-CoV nucleocapsid protein.
-
Réactivité croisée
- SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
-
Purification
- Affinity purified by Protein G.
-
Immunogène
- The immunogen used to generate this antibody corresponds to SARS-CoV Nucleocapsid (121-422 a.a.).
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- WB: 1:1000-1:10000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.5 mg/mL
-
Buffer
- PBS, No Preservative
-
Agent conservateur
- Without preservative
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Autre désignation
- SARS-CoV-2 Nucleocapsid
-
Sujet
- 2019-nCoV Nucleocapsid , SARS-CoV-2 Nucleocapsid , COVID-19 Nucleocapsid , 2019-nCoV NP , SARS-CoV-2 NP , COVID-19 NP
Antigène
-